ImpriMed Presents New Research Findings at The Veterinary Cancer Society (VCS) Mid-Year Conference
PALO ALTO, CA, UNITED STATES, May 2, 2022 /EINPresswire.com/ -- Palo Alto, CA - ImpriMed, Inc., a leading veterinary precision medicine startup, is pleased to announce their latest data was selected by the Veterinary Cancer Society Executive committee …